Acadia Healthcare Company, Inc. (ACHC) — ESG & Values Scores

Environment story

Acadia Healthcare discloses minimal environmental data and lacks quantified Scope 1, 2, and 3 emissions metrics. The 10-K acknowledges climate-change operational risks and medical-waste handling but provides no net-zero targets, renewable energy percentages, or decarbonization initiatives. No environmental controversies or fines are reported. The company's environmental disclosure is sparse; absence of ambitious targets and verifiable emissions reductions warrants a mid-range score reflecting regulatory compliance posture rather than proactive climate leadership.

Criticisms on file

No disclosed environmental contamination, fines, or remediation activities at current or formerly operated facilities; however, acknowledges potential for unknown environmental conditions at prior sites.
Source: ACHC 10-K, Item 7 MD&A, Environmental Matters section; Item 1A Risk Factors, Operational Risks.

Disclosed initiatives

Medical Waste Management Compliance

Each facility maintains agreements with waste management companies for disposal of infectious and hazardous medical waste per federal, state, and local environmental laws.

Operational regulatory compliance; no quantified emission reduction stated.
Climate Risk Awareness

10-K acknowledges potential business disruption from natural disasters and climate change affecting facility locations.

Risk acknowledgment only; no mitigation strategy disclosed.

Social story

Acadia Healthcare reports approximately 74% female workforce and 51% people of color, exceeding diversity benchmarks. However, the company discloses minimal executive/board-level diversity percentages. CEO-to-median-worker pay ratio is not disclosed. One facility holds a labor-union agreement (130 employees of ~25,000 total), indicating low unionization. The 10-K emphasizes talent retention challenges, rising labor costs, and turnover—common in healthcare but not quantified. No documented union-suppression activities or major strikes are reported. Supply-chain labor audits and living-wage commitments are not disclosed. Overall, the company demonstrates baseline diversity commitment but lacks granular leadership diversity data and supply-chain human-rights oversight.

Criticisms on file

Rising labor costs and turnover; resort to expensive contract labor in certain facilities due to shortages of nurses, addiction counselors, and medical support personnel.
Source: ACHC 10-K, Item 1 Business, Human Capital section and Item 1A Risk Factors, Human Capital Risks.
Desert Hills Litigation: Large sexual-abuse and mistreatment claims resulting in $400 million settlement (2023), indicating potential care-quality deficiencies and safeguarding failures.
Source: ACHC 10-K, Item 1A Risk Factors, Legal Proceedings and Regulatory Risks; Note 11 Commitments and Contingencies.
Patient incidents including deaths, sexual abuse, assaults, and elopements have occurred; admissions holds and regulatory actions imposed.
Source: ACHC 10-K, Item 1A Risk Factors, Operational Risks.

Disclosed initiatives

Inclusive Workplace Culture Policy

Company policies prohibit discrimination based on race, color, national origin, age, religion, disability, gender, marital status, veteran status, and other protected classes.

Legal compliance; non-discriminatory hiring and retention framework in place.
Total Rewards Program

Comprehensive benefits including medical, dental, vision, disability, HSA/FSA, 401(k) with match, paid time off, and employee assistance programs.

Workforce retention and well-being; designed to attract and retain talent amid staffing competition.
Employee Satisfaction Surveys

Comprehensive surveys conducted to assess and respond to employee concerns and desires.

Feedback mechanism for organizational improvement; no quantified outcomes disclosed.
Workplace Safety Training

Access to workplace safety training programs and continuous evaluation of policies promoting employee safety and patient care.

Occupational health and safety management; no specific metrics provided.

Governance story

Acadia Healthcare does not disclose board independence percentage or share-class structure in the provided 10-K excerpts. The company acknowledges exposure to activist-investor campaigns and the potential for proxy contests, indicating governance tension. No single-class share structure is explicitly described, suggesting likely standard governance; however, absence of confirmation prevents verification of dual-class risks. Lobbying expenditures and specific anti-climate regulatory lobbying are not disclosed. The company faces material litigation (Desert Hills: $400M settlement 2023) and ongoing federal/state investigations for False Claims Act, Anti-Kickback Statute, and Stark Law compliance—representing significant governance and compliance risk. Activist-shareholder actions and governance uncertainty are material concerns. Overall, governance score reflects undisclosed board metrics, material litigation exposure, and regulatory scrutiny.

Criticisms on file

Desert Hills Litigation: Jury awarded $80 million compensatory and $405 million punitive damages (July 7, 2023) for sexual abuse and mistreatment; company settled for $400 million covering this case plus two related lawsuits. Additional lawsuit with similar facts filed.
Source: ACHC 10-K, Item 1A Risk Factors, Legal Proceedings and Regulatory Risks; Item 7 MD&A Risk Management and Insurance.
Multiple ongoing federal and state investigations into potential False Claims Act, Anti-Kickback Statute, Stark Law, and EKRA violations; qui tam (whistleblower) lawsuits possible under seal.
Source: ACHC 10-K, Item 1A Risk Factors, Legal Proceedings and Regulatory Risks.
Activist investors have sought to effect changes to board composition and strategic direction; proxy contests or 'vote no' campaigns constitute ongoing governance uncertainty.
Source: ACHC 10-K, Item 1A Risk Factors, Activist investors section.
Insurance coverage deterioration: Commercial liability insurance for September 2025+ contains exclusions for sexual molestation/abuse incidents, higher premiums, and lower aggregate limits, indicating elevated claims history and reduced risk appetite by insurers.
Source: ACHC 10-K, Item 1A Risk Factors, Legal Proceedings—Insurance section.
Large self-insured retention ($10–$25 million per claim depending on claim type) exposes company to material uninsured liability; reinsurance cap of $75–$80 million may prove inadequate for future large claims.
Source: ACHC 10-K, Item 7 MD&A, Risk Management and Insurance.

Disclosed initiatives

Regulatory Compliance Framework

Company discloses compliance programs addressing Anti-Kickback Statute, Stark Law, EKRA, HIPAA, Part 2 (SUD Records), EMTALA, and false-claims prevention. Compliance is described as subject to 'considerable scrutiny' and ongoing review.

Risk mitigation; no quantified compliance cost or effectiveness metrics disclosed.
Internal Controls and Sarbanes-Oxley Section 404 Compliance

Company required to maintain internal controls over financial reporting per SOX 404; periodic assessment conducted.

Financial-reporting integrity; failure to maintain effective controls could trigger SEC violations and debt-covenant breaches.
Data Privacy and Security Program

Policies and procedures in place to protect PHI and SUD Records per HIPAA and Part 2 regulations; security breach notification protocols established.

Patient privacy protection; no material data breaches reported to date, but breach risk acknowledged.

These are Missionomics' own editorial scores — directional signals built from disclosed facts under a published method, not certifications or definitive ratings of Acadia Healthcare Company, Inc.. Coverage and confidence vary by data point, and figures can lag real-world changes. Read the full Methodology for sourcing, scoring, and correction details — or open Acadia Healthcare Company, Inc. in the app for interactive charts and portfolio building.

More in Healthcare

Eli Lilly and Company (LLY) Johnson & Johnson (JNJ) AbbVie Inc. (ABBV) UnitedHealth Group Incorporated (UNH) Merck & Co., Inc. (MRK) Thermo Fisher Scientific Inc. (TMO)